Drug intelligence / Profile preview

phleum pratense grass pollen allergen extract + desloratadine

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Small Molecules
Administration
Sublingual, Subcutaneous, Oral
01

Overview

This is a **combination drug** comprising two distinct components: **phleum pratense grass pollen allergen extract** and **desloratadine**. - **Phleum pratense grass pollen allergen extract** is an allergenic extract derived from Timothy grass pollen, commonly used as immunotherapy for the treatment of grass pollen-induced allergic rhinitis and conjunctivitis[1][7]. The mechanism involves administration of controlled allergen doses to induce tolerance by promoting immune modulation, typically increasing IgG antibodies and blunting the seasonal rise of IgE, and reducing hypersensitivity responses[8]. - **Desloratadine** is a second-generation antihistamine that acts as an antagonist at the histamine H1 receptor, blocking histamine-mediated allergic symptoms such as sneezing, itching, and runny nose. It does not cross the blood–brain barrier readily and is less sedating than first-generation antihistamines. The combination is intended for patients suffering from seasonal allergic rhinitis/hay fever due to grass pollen, providing both allergen-specific immunotherapy (disease-modifying) and immediate symptomatic relief[1][3][7].

Brand names
GrazaxAerius
Other names
Phleum pratense allergen extract + desloratadine
02

Targets

Grass pollen-specific IgE antibodies / antigen-antibody interfaceHRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on phleum pratense grass pollen allergen extract + desloratadine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phleum pratense grass pollen allergen extract + desloratadine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call